This is a request for five years of core support beginning September 1, 1980 following the termination of NCI Grant CA 14051. The Cancer Center Support (Core) Grant is requested to provide funds for shared facilities and services, including research salaries for professional staff (the faculty members who as a group operate the program of the Center), centralized services, shared equipment, developmental funds, and administration. Research will be carried out in three main areas of Cancer Biology: 1) Cancer Virology - this group, led by five faculty members, concentrates primarily on the identification of cancer-inducing genes and their products. 2) Cancer Immunology - this program, led by three faculty members, places its major effort in the study of the mechanism by which killer T lymphocytes destroy foreign or cancer cells in vivo and in vitro. 3) Cancer Cell Biology, with four faculty members, explores the biochemical changes that occur on the cell surface and in the cytoskeleton as a result of mailignant transformation. This Core Grant will aid further development of the Center by providing partial support for initial research costs of two new faculty members: a replacement in the Immunology Group and an addition to the Cell Biology Group. Development funds are also requested for the support of exploratory projects in the initial phase, prior to application for peer-reviewed funding.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts Institute of Technology
Organized Research Units
United States
Zip Code
Berger, Gilles; Grauwet, Korneel; Zhang, Hong et al. (2018) Anticancer activity of osmium(VI) nitrido complexes in patient-derived glioblastoma initiating cells and in vivo mouse models. Cancer Lett 416:138-148
Lo, Justin H; Hao, Liangliang; Muzumdar, Mandar D et al. (2018) iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer. Mol Cancer Ther 17:2377-2388
Phillips, Angela M; Doud, Michael B; Gonzalez, Luna O et al. (2018) Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife 7:
Johnson, Hannah; White, Forest M (2018) Quantitative Analysis of Tyrosine Kinase Signaling Across Differentially Embedded Human Glioblastoma Tumors. Methods Mol Biol 1711:149-164
Tentori, Augusto M; Nagarajan, Maxwell B; Kim, Jae Jung et al. (2018) Quantitative and multiplex microRNA assays from unprocessed cells in isolated nanoliter well arrays. Lab Chip 18:2410-2424
Parisi, Tiziana; Balsamo, Michele; Gertler, Frank et al. (2018) The Rb tumor suppressor regulates epithelial cell migration and polarity. Mol Carcinog 57:1640-1650
Gam, Jeremy J; Babb, Jonathan; Weiss, Ron (2018) A mixed antagonistic/synergistic miRNA repression model enables accurate predictions of multi-input miRNA sensor activity. Nat Commun 9:2430
Chen, Huihui; Cho, Kin-Sang; Vu, T H Khanh et al. (2018) Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun 9:3209
Tam, Brooke E; Hao, Yining; Sikes, Hadley D (2018) An examination of critical parameters in hybridization-based epigenotyping using magnetic microparticles. Biotechnol Prog 34:1589-1595
Ramadi, Khalil B; Dagdeviren, Canan; Spencer, Kevin C et al. (2018) Focal, remote-controlled, chronic chemical modulation of brain microstructures. Proc Natl Acad Sci U S A 115:7254-7259

Showing the most recent 10 out of 904 publications